Thomas Mark Haberman, DPM in Bel Aire, KS - Podiatrist

Thomas Mark Haberman, DPM is a Podiatrist based in Bel Aire, Kansas. Thomas Mark Haberman is licensed to practice in Kansas (license number 12-00296) and his current practice location is 4524 N Fritillary Ct, Bel Aire, Kansas. He can be reached at his office (for appointments etc.) via phone at (316) 577-5038.

NPI number for Thomas Mark Haberman is 1619045523 and his current mailing address is 4524 N Fritillary Ct, Bel Aire, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1619045523.

Contact Information

	Thomas Mark Haberman, DPM
	4524 N Fritillary Ct, Bel Aire, KS 67226-4204
	(316) 577-5038
	(316) 744-6404

Healthcare Provider's Profile

Full Name	Thomas Mark Haberman
Gender	Male
Speciality	Podiatrist
Location	4524 N Fritillary Ct, Bel Aire, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1619045523
Provider Enumeration Date: 11/30/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Thomas Mark Haberman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1619045523	NPI	-	NPPES
100315210B	Medicaid	KS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	12-00296 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas Mark Haberman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Thomas Mark Haberman, DPM 4524 N Fritillary Ct, Bel Aire, KS 67226-4204 Ph: (316) 577-5038	Thomas Mark Haberman, DPM 4524 N Fritillary Ct, Bel Aire, KS 67226-4204 Ph: (316) 577-5038

News Archive

Extra weight gain during lockdown could have significant health implications, cardiologist warns

Many more of us could have diabetes and high blood pressure if we don't lose the extra weight we've put on during lockdown, a renowned cardiologist at Keele University has warned.

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

Ligand Pharmaceuticals Incorporated partner GlaxoSmithKline announced that today, the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion recommending marketing authorization for GSK's REVOLADE (eltrombopag) as a treatment for low platelet counts (thrombocytopenia) in adult patients with chronic hepatitis C infection, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy

With contraception issue, Santorum highlights conservative credentials

Rep. Paul Ryan (R-Wis.), argued this morning on NBC's Meet the Press program that Obama's desire to have most religious hospitals provide birth control coverage to employees is "not an issue about contraception." ... But Rep. Chris Van Hollen (D-Md.) sharply disagreed, accusing Republicans of harping on "red-meat social issues that rile up their base."

Prompt attention may limit recurrence risk in TIA patients

Centres with procedures in place for the rapid assessment of patients with transient ischaemic attack or minor stroke achieve low recurrence rates in these patients, a multinational study shows.

Postmenopausal women who quit smoking can reduce risk of heart disease, regardless of diabetes

Postmenopausal women who quit smoking reduced their risk of heart disease, regardless of whether they had diabetes, according to a new study conducted by Juhua Luo, an epidemiologist at the Indiana University School of Public Health-Bloomington.

Thomas Mark Haberman, DPM - Podiatrist in Bel Aire, KS